Table 3 Chemokines and growth factors profile
From: Septic shock in older people: a prospective cohort study
Young | Elderly | Group A vs. B | |||||
|---|---|---|---|---|---|---|---|
Control n=36 | Septic shock (group A) n=21 | p-value | Control n=8 | Septic shock (group B) n=8 | p-value | p-value | |
EGF | 266 ± 212 | 212 ± 182 | 0.264 | 192 ± 80 | 250 ± 213 | 0.600 | 0.696 |
FGF2 | 122 ± 62 | 133 ± 55 | 0.301 | 113 ± 45 | 153 ± 67 | 0.344 | 0.575 |
FITL3 | 6.27 ± 11.4 | 18 ± 165 | 0.000 | 6.25 ± 14.04 | 16 ± 27 | 0.235 | 0.104 |
FRAKTALINE | 167 ± 81 | 573 ± 858 | 0.001 | 120 ± 73 | 296 ± 273 | 0.027 | 0.251 |
GCSF | 156 ± 196 | 3662 ± 7100 | 0.001 | 104 ± 106 | 3226 ± 7166 | 0.093 | 0.922 |
GMCSF | 32 ± 21 | 125 ± 284 | 0.000 | 48 ± 65 | 54 ± 43 | 0.208 | 0.241 |
GRO | 1958 ± 1642 | 2644 ± 3934 | 0.772 | 1733 ± 884 | 4074 ± 4718 | 0.753 | 0.435 |
MCP-1 | 610 ± 912 | 2806 ± 4334 | 0.002 | 916 ± 1129 | 3237 ± 4792 | 0.171 | 1.0 |
MCP-3 | 24 ± 13 | 58 ± 44 | 0.001 | 11.62 ± 5.20 | 32 ± 25 | 0.023 | 0.130 |
MDC | 817 ± 719 | 714 ± 471 | 0.869 | 745 ± 350 | 625 ± 265 | 0.208 | 0.527 |
MIP-1 | 23 ± 22 | 50 ± 65 | 0.069 | 322 ± 871 | 39 ± 25 | 0.127 | 0.696 |
MIP-1 | 42 ± 25 | 102 ± 83 | 0.000 | 35 ± 31 | 94 ± 60 | 0.027 | 0.678 |
VEGF | 227 ± 306 | 310 ± 239 | 0.003 | 143 ± 115 | 392 ± 387 | 0.021 | 0.678 |